ADCT
ADC Therapeutics SA
Key Financials
Revenue
$81.4M
↑ 14.9%
Net Income
$-142623000
↑ 9.6%
Total Assets
$323.1M
↑ 0.4%
EPS (Diluted)
$-1.12
↑ 30.9%
Operating Income
$-121499000
↑ 7.0%
Total Liabilities
$509.0M
↓ 3.0%
Shareholders' Equity
$-185834000.00
↑ 8.3%
Cash & Equivalents
$261.3M
↑ 4.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/4/2026 | View on SEC |
| 8-K | 5/4/2026 | View on SEC |
| SCHEDULE 13G/A | 4/24/2026 | View on SEC |
| DEFA14A | 4/20/2026 | View on SEC |
| DEF 14A | 4/20/2026 | View on SEC |
| 424B3 | 4/15/2026 | View on SEC |
| PRE 14A | 4/10/2026 | View on SEC |
| SCHEDULE 13G/A | 4/6/2026 | View on SEC |
| 4 | 4/2/2026 | View on SEC |
| EFFECT | 3/16/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ADCT |
| Company Name | ADC Therapeutics SA |
| CIK | 1771910 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | V8 |
| Phone | 41 21 653 02 00 |